LPS preconditioning ameliorates intestinal injury in a rat model of hemorrhagic shock

Inflammation Research

Volumn 63, Issue 8, 2014, Pages 675-682

  Chang, Ruiming ^a   Wang, Yingyan ^b   Chang, Jianxing ^a   Wen, Liqiang ^a   Jiang, Zhipeng ^a   Yang, Tao ^a   Yu, Kai ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b GUANGDONG PROVINCIAL HOSPITAL OF CHINESE MEDICINE   (China)

Author keywords

Hemorrhagic shock; Intestinal mucosa; LPS tolerance; TFF3; TLR4; TNF

Indexed keywords

CASP3 PROTEIN, RAT; CASPASE 3; LIPOPOLYSACCHARIDE; NEUROPEPTIDE; TFF3 PROTEIN, RAT; TLR4 PROTEIN, RAT; TOLL LIKE RECEPTOR 4;

ANIMAL; DRUG EFFECTS; ILEUM; INTESTINE MUCOSA; MALE; METABOLISM; PATHOLOGY; RAT; REPERFUSION INJURY; SHOCK, HEMORRHAGIC; SPRAGUE DAWLEY RAT;

ANIMALS; CASPASE 3; ILEUM; INTESTINAL MUCOSA; LIPOPOLYSACCHARIDES; MALE; NEUROPEPTIDES; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY; SHOCK, HEMORRHAGIC; TOLL-LIKE RECEPTOR 4;

EID: 84904384194     PISSN: 10233830     EISSN: 1420908X     Source Type: Journal    
DOI: 10.1007/s00011-014-0740-6     Document Type: Article

References (37)

1. Souza DG, Bertini R, Vieira AT, Cunha FQ, Poole S, Allegretti M, et al. Repertaxin, a novel inhibitor of rat CXCR2 function, inhibits inflammatory responses that follow intestinal ischaemia and reperfusion injury. Br J Pharmacol. 2004;143:132-42. (Pubitemid 39280032)
2. Eror AT, Stojadinovic A, Starnes BW, Makrides SC, Tsokos GC, Shea-Donohue T. Antiinflammatory effects of soluble complement receptor type 1 promote rapid recovery of ischemia/reperfusion injury in rat small intestine. Clin Immunol. 1999;90:266-75. (Pubitemid 29162173)
3. Proctor LM, Arumugam TV, Shiels I, Reid RC, Fairlie DP, Taylor SM. Comparative anti-inflammatory activities of antagonists to C3a and C5a receptors in a rat model of intestinal ischaemia/reperfusion injury. Br J Pharmacol. 2004;142:756-64. (Pubitemid 38969670)
4. Hsieh YH, McCartney K, Moore TA, Thundyil J, Gelderblom M, Manzanero S, et al. Intestinal ischemia-reperfusion injury leads to inflammatory changes in the brain. Shock. 2011;36:424-30.
5. Sansonetti PJ. The innate signaling of dangers and the dangers of innate signaling. Nat Immunol. 2006;7:1237-42. (Pubitemid 46111240)
6. Meylan E, Tschopp J, Karin M. Intracellular pattern recognition receptors in the host response. Nature. 2006;442:39-44. (Pubitemid 44064203)
7. Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell. 2006;124:783-801. (Pubitemid 43261452)
8. Chang JX, Chen S, Ma LP, Jiang LY, Chen JW, Chang RM, et al. Functional and morphological changes of the gut barrier during the restitution process after hemorrhagic shock. World J Gastroenterol. 2005;11:5485-91. (Pubitemid 41684706)
9. Nomura F, Akashi S, Sakao Y, Sato S, Kawai T, Matsumoto M, et al. Cutting edge: endotoxin tolerance in mouse peritoneal macrophages correlates with down-regulation of surface toll-like receptor 4 expression. J Immunol. 2000;164:3476-9. (Pubitemid 30169796)
10. Broad A, Jones DE, Kirby JA. Toll-like receptor (TLR) response tolerance: a key physiological "damage limitation" effect and an important potential opportunity for therapy. Curr Med Chem. 2006;13:2487-502. (Pubitemid 44364151)
11. Johnson BJ, Le TT, Dobbin CA, Banovic T, Howard CB, Flores FM, et al. Heat shock protein 10 inhibits lipopolysaccharide-induced inflammatory mediator production. J Biol Chem. 2005;280:4037-47. (Pubitemid 40288567)
12. Ogawa H, Rafiee P, Heidemann J, Fisher PJ, Johnson NA, Otterson MF, et al. Mechanisms of endotoxin tolerance in human intestinal microvascular endothelial cells. J Immunol. 2003;170:5956-64. (Pubitemid 36682575)
13. Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, Edberg S, Medzhitov R. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell. 2004;118:229-41. (Pubitemid 38962578)
14. Nemazee D, Gavin A, Hoebe K, Beutler B. Immunology: toll-like receptors and antibody responses. Nature. 2006;441:E4 (discussion E4).
15. Michelsen KS, Arditi M. Toll-like receptors and innate immunity in gut homeostasis and pathology. Curr Opin Hematol. 2007;14:48-54. (Pubitemid 44885612)
16. Cario E, Rosenberg IM, Brandwein SL, Beck PL, Reinecker HC, Podolsky DK. Lipopolysaccharide activates distinct signaling pathways in intestinal epithelial cell lines expressing Toll-like receptors. J Immunol. 2000;164:966-72. (Pubitemid 30043724)
17. Fukata M, Michelsen KS, Eri R, Thomas LS, Hu B, Lukasek K, et al. Toll-like receptor-4 is required for intestinal response to epithelial injury and limiting bacterial translocation in a murine model of acute colitis. Am J Physiol Gastrointest Liver Physiol. 2005;288:G1055-65. (Pubitemid 40563149)
18. Strieter RM, Kunkel SL, Bone RC. Role of tumor necrosis factor-alpha in disease states and inflammation. Crit Care Med. 1993;21:S447-63. (Pubitemid 23304335)
19. Porter AG, Janicke RU. Emerging roles of caspase-3 in apoptosis. Cell Death Differ. 1999;6:99-104. (Pubitemid 29082297)
20. Barrera GJ, Sanchez G, Gonzalez JE. Trefoil factor 3 isolated from human breast milk downregulates cytokines (IL8 and IL6) and promotes human beta defensin (hBD2 and hBD4) expression in intestinal epithelial cells HT-29. Bosn J Basic Med Sci. 2012;12:256-64.
21. Science TMo, China TotPsRo. Guidance suggestions for the care and use of laboratory animals: MSTPRC Beijing, 2006-9-30.
22. Endo Y, Shibazaki M, Yamaguchi K, Kai K, Sugawara S, Takada H, et al. Enhancement by galactosamine of lipopolysaccharide(LPS)-induced tumour necrosis factor production and lethality: its suppression by LPS pretreatment. Br J Pharmacol. 1999;128:5-12. (Pubitemid 29425261)
23. Ypsilantis P, Lambropoulou M, Tentes I, Kortsaris A, Papadopoulos N, Simopoulos C. Mesna protects intestinal mucosa from ischemia/reperfusion injury. J Surg Res. 2006;134:278-84. (Pubitemid 44092802)
24. Zhai Z, Gomez-Mejiba SE, Gimenez MS, Deterding LJ, Tomer KB, Mason RP, et al. Free radical-operated proteotoxic stress in macrophages primed with lipopolysaccharide. Free Radic Biol Med. 2012;53:172-81.
25. Murphey ED, Fang G, Varma TK, Sherwood ER. Improved bacterial clearance and decreased mortality can be induced by LPS tolerance and is not dependent upon IFN-gamma. Shock. 2007;27:289-95.
26. West MA, Heagy W. Endotoxin tolerance: a review. Crit Care Med. 2002;30:S64-73. (Pubitemid 34131164)
27. Granowitz EV, Porat R, Mier JW, Orencole SF, Kaplanski G, Lynch EA, et al. Intravenous endotoxin suppresses the cytokine response of peripheral blood mononuclear cells of healthy humans. J Immunol. 1993;151:1637-45. (Pubitemid 23219302)
28. Echtenacher B, Mannel DN. Requirement of TNF and TNF receptor type 2 for LPS-induced protection from lethal septic peritonitis. J Endotoxin Res. 2002;8:365-9. (Pubitemid 35460671)
29. Schwarz NT, Engel B, Eskandari MK, Kalff JC, Grandis JR, Bauer AJ. Lipopolysaccharide preconditioning and cross-tolerance: the induction of protective mechanisms for rat intestinal ileus. Gastroenterology. 2002;123:586-98. (Pubitemid 34827202)
30. Tasaki K, Ruetzler CA, Ohtsuki T, Martin D, Nawashiro H, Hallenbeck JM. Lipopolysaccharide pre-treatment induces resistance against subsequent focal cerebral ischemic damage in spontaneously hypertensive rats. Brain Res. 1997;748:267-70. (Pubitemid 27094913)
31. Wong WM, Poulsom R, Wright NA. Trefoil peptides. Gut. 1999;44:890-5. (Pubitemid 29244230)
32. Rupani B, Caputo FJ, Watkins AC, Vega D, Magnotti LJ, Lu Q, et al. Relationship between disruption of the unstirred mucus layer and intestinal restitution in loss of gut barrier function after trauma hemorrhagic shock. Surgery. 2007;141:481-9. (Pubitemid 46441309)
33. Leaphart CL, Cavallo J, Gribar SC, Cetin S, Li J, Branca MF, et al. A critical role for TLR4 in the pathogenesis of necrotizing enterocolitis by modulating intestinal injury and repair. J Immunol. 2007;179:4808-20.
34. Watanabe T, Higuchi K, Kobata A, Nishio H, Tanigawa T, Shiba M, et al. Non-steroidal anti-inflammatory drug-induced small intestinal damage is Toll-like receptor 4 dependent. Gut. 2008;57:181-7. (Pubitemid 351158044)
35. Wang J, Ouyang Y, Guner Y, Ford HR, Grishin AV. Ubiquitin-editing enzyme A20 promotes tolerance to lipopolysaccharide in enterocytes. J Immunol. 2009;183:1384-92.
36. Cario E, Brown D, McKee M, Lynch-Devaney K, Gerken G, Podolsky DK. Commensal-associated molecular patterns induce selective toll-like receptor-trafficking from apical membrane to cytoplasmic compartments in polarized intestinal epithelium. Am J Pathol. 2002;160:165-73. (Pubitemid 34052277)
37. Furrie E, Macfarlane S, Thomson G, Macfarlane GT. Toll-like receptors-2, -3 and -4 expression patterns on human colon and their regulation by mucosal-associated bacteria. Immunology. 2005;115:565-74. (Pubitemid 41032444)